|
MANAGEMENT TEAM
Dr. Carleton Hsia, Chairman of the Board,
Chief Executive Officer (CEO) Dr. Hsia, a former
professor of pharmacology and biochemistry at the University of
Toronto, is a pioneer in the blood substitute field. He co-founded
and until 1992 served as Vice President of Research and Development
for Hemosol, a public Canadian biotechnology company, that develops
blood substitutes based on Dr. Hsia's inventions. Dr. Hsia, whose
inventions are patented worldwide, founded SynZyme Technologies in
1992, and has served as the Company's Chairman and Chief Executive
Officer since then. He is the recipient of numerous peer-reviewed
NIH SBIR grants and DOD contracts totaling over $11 million. He has
also raised over $5 million in private funding for SynZyme in the
past. Dr. Hsia earned his Ph.D. at the University of Hawaii in
1968, with a dissertation on the use of nitroxide spin labels in the
study of the ligand-binding behavior of immunoglobulin and its
relationship to the immune response. He has more than 70
peer-reviewed publications and ?? issued patents.
Mr. Robert Patterson, President Robert E.
Patterson has 31 years of experience providing legal counsel to high
tech business clients. He advises clients on a variety of matters
including startup issues and the formation of new businesses
predicated on technology. He was named as one of Silicon Valle’s top
corporate lawyers in May 2003 by San Jose Magazine. Mr. Patterson
works closely with venture capital investors in investment and
operation activities. He has assisted non-US corporations in their
formation, acquisition and operation of US companies. He serves as a
director of several biotechnology-based corporations. He has been a
director and member of the investment committee of an international
venture capital fund since 1983 and, in that regard, has negotiated
numerous venture capital investments both as a lawyer and, on
occasion, an investor. He is a founding partner of a
technology-focused SBIC venture fund. Mr. Patterson received his
J.D. from Stanford University in 1972 and is admitted to practice in
California.
Mr. Michael Kelley, Government Affair Officer
Dr. Li Ma, Chief Scientific Officer Dr.
Ma is an associate professor at Georgia Southern University. She
received a Ph.D. in chemistry from the University of Georgia, an
M.S. in physics from the Chinese University of Science and
Technology, and was a post-doctoral fellow in the Department of
Molecular Biology and Biochemistry at the University of California,
Irvine. Dr. Ma served as SynZyme's Research Director from 1992 to
1998 and VP of R&D from 1998 to 2002
Back to top
Ms. Evlin
Chang, Controller
Ms. Chang has over twenty years experience managing financial
operations in a wide variety of businesses. From 1990 to 1996, and
in the first half of 1998, Ms. Chang served as the controller of
Mark One Mortgage, an Orange County, California-based mortgage
lender. She has served in a similar capacity at the Placentia
Gallery (1997), the Anaheim YMCA (1995-1996), and Irvine-based Data
Clean Corporation (1988-1990). Ms. Chang also worked as an
accounting manager at Intex Corporation (1980-1988), and as an
accountant at Varco International (1976-1980). She received a B.S.
in business administration from the California State University at
Los Angeles.
Back to top
|
